Market Research Blog – Page 1012 – New Product Development

Global Pre-Printed Tape Market Expected to Reach USD 55.4 Billion by 2033, Driven by Technological Advancements and Attractive Packaging

The global pre-printed tape market is estimated to be valued at USD 41.2 billion in 2023, with a projected increase at a CAGR of 3% during the forecast period from 2023 to 2033. By the end of the forecast period, the market share is expected to reach USD 55.4 billion, driven by factors such as attractive packaging, product differentiation, and technological advancements in the printing industry.

Key Insights:

Growing Demand for Attractive Packaging: The demand for pre-printed tape is witnessing notable growth in the printing industry, driven by the need for attractive packaging and product differentiation. Pre-printed tapes, also known as custom-printed tapes, contain product-related information and help in decreasing pilferage by preventing unnoticed tampering.
Cost-Effectiveness and High Quality: Pre-printed tapes offer cost-effectiveness and high quality, making them an attractive option for businesses. They help in reducing carton costs by eliminating the need for printed cartons, and facilitate easy tracing of lost shipments.
Challenges and Restraints: Despite the significant growth opportunities, challenges such as the high cost of high-quality printing and fluctuations in raw material prices may act as restraints for the sales of pre-printed tapes. Building a printing plant requires substantial capital investment, posing a challenge for market players.

Regional Performance:

North America: The demand for pre-printed tape in North America is expected to expand at an average rate of 28%, driven by the transition of the printing industry from conventional to digital printing machines. Pre-printed tapes are increasingly used in the region for communicating handling instructions, boosting market growth.
Europe: Similarly, Europe is witnessing steady growth in the demand for pre-printed tape, with an estimated expansion rate of 24%. The region is experiencing a shift towards digital printing technology, driving the adoption of pre-printed tapes for various packaging applications.

Global Pre-Printed Tape Market: Dynamics

Rapid growth in the printing industry, coupled with demand for attractive packaging, product differentiation, and technological advancements are the key drivers for the growth in the pre-printed tape market. In addition, there are several advantages associated with pre-printed tapes that further accelerates the growth in the pre-printed tape market. Some of the advantages and benefits are: it reduces pilferage as printed tape cannot be broken and resealed without detection, it helps in reducing carton costs as it nullifies the need of carrying inventories of printed cartons, it helps in tracing lost shipments etc.

Digital printing in the pre-printed tape market is anticipated to be the fastest growing technology, owing to its attractive and cost effective solution for manufacturing high quality pre-printed tapes. However, higher cost of high quality printing and evaporation of ink may act as restraining factors for the growth in the pre-printed tape market.

Key Players

Some of the major players of the global pre-printed tape market are Castle Tapes Holdings, ADH Tape, Ameripak, Preferred Tape, Inc., Nadco Tapes & Labels, Inc., Intertape Polymer Group, ProtoPak Engineering Corporation, and many more.

The report is a compilation of first-hand information, qualitative, and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Access Full Report: https://www.futuremarketinsights.com/reports/pre-printed-tape-market

Market Segmentation:

Based on printing technology:

Lithography
Flexography
Digital printing
Screen printing
Others

Based on material:

Polypropylene (PP)
Polyethylene (PE)
Polyvinyl Chloride (PVC)
Aluminum and copper foils
Others

Based on adhesive type:

Hot-Melt
Acrylic
Solvent-based
Water-based
Others

Based on application:

Bundling
Carton Sealing
Tamper Evident Seals
Product and Company Identification
Other

Based on end-use industries:

Food & Beverage
Pharmaceuticals
Cosmetics & toiletries
Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Pouch Tapes Market to Reach USD 1.24 Billion by 2033 Driven by Demand from New End-User Verticals

The global pouch tapes market is projected to reach a valuation of USD 1.24 billion by 2033, growing from USD 979.25 million in 2023 at a CAGR of 2.4% during the forecast period from 2023 to 2033, according to the latest report.

Market Overview: The pouch tapes market is expected to see substantial growth due to increasing demand from various new end-user verticals in recent years. Pouch tapes, known for their pressure-sensitive properties, are extensively used for attaching documents, invoices, literature, and samples to packages, ensuring efficient shipping and logistics processes.

Key Growth Drivers:

High Tacking Properties: Pouch tapes are favored for their ability to adhere strongly to packages without causing damage to the contents inside. This makes them essential in shipping and logistics, where document integrity is crucial.
Moisture and Abrasion Resistance: The rising demand for pouch tapes is driven by their protective features, including moisture resistance and abrasion resistance, which are critical for preserving package quality during transit.
Improved Visibility: Pouch tapes provide a transparent window for easy document identification, making them increasingly desirable for marketing and branding purposes. This functionality enhances operational efficiency by simplifying the identification of package contents.

Pouch Tapes Market: Market Introduction

The global adhesive tapes market is worth over 40 Bn and is expected to expand at a CAGR of over 4.5% over the forecast period resulting in the growth of pouch tapes market. Pouch tapes are types of pressure sensitive tapes used for attaching documents, literature and samples to packages. Pouch tapes have high tacking property and are used for attaching documents in shipping and logistics, e-commerce, and others.

Due to these, there has been a growing preference for pouch tapes. Pouch tapes have barrier properties such as moisture resistant, abrasion resistant etc. Pouch tapes have high tacking property which prevents rubbing off, to reduce the chance of lost or delayed packages and also invoices and bar codes from becoming scuffed and non-legible.

Pouch tapes provide a see-through window for easy document identification. Therefore, the outlook for the global pouch tapes market growth is expected to be positive, over the forecast period.

Pouch Tapes Market: Market Dynamics

Shipping and logistics sector is expected to grow on the backdrop of e-commerce growth, resulting in the increase in market share of pouch tapes. The key features leading to the demand for pouch tapes is high resistance to moisture and abrasion, which can be used in adverse climatic conditions, keeping the inside documents safe.

Pouch tapes have tacky borders, resulting in strong adhesion for attaching and protecting shipping documents, packing lists, information and work instructions etc. Furthermore, strong adhesives prevents rubbing off the pouch tapes, thus reducing the chance of lost or delaying of packages.

The non-tacky center part provides a see-through window for easy document identification resulting in propelled market share of pouch tapes. Pouch tapes are linerless, reducing the waste disposal, thus resulting in reduced carbon emission. Pouch tapes offers less material usage which reduces the transportation and storage cost accentuating the market share of pouch tapes.

Pouch tapes are easy to use, reduced price, and exhibit good performance in various applications such as attaching and protecting shipping documents, attaching invoices, product samples etc. Pouch tapes are light in weight as it does not increases the overall weight of the products to be shipped, thus reducing the transportation cost. Pouch Tapes provide a quick, simple and secure method of attaching documents to shipping containers fuels the growth of the pouch tapes market.

Despite the favorable condition towards the growth of pouch tapes market, there are certain factors that hinders the pouch tapes market is the stringent government regulations towards the use of plastics. Moreover, substitute products such as document pouches can hamper the growth of pouch tapes market.

Pouch Tapes Market: Market Dynamics

Pouch tapes market has been segmented on the basis of the region into North America, Europe, Asia Pacific, Middle East & Africa (MEA), and Latin America. North America is expected to dominate the market share of pouch tapes over the forecast period owing to increase in shipping and logistics activity in the region.

Western Europe is anticipated to follow North America in terms of growth rate due to mature market. Asia Pacific region is expected to register highest growth rate over the forecast period due to increase of e-commerce sector in the sector resulting in the consumer preference towards online purchasing. MEA region is expected to register slow growth over the forecast period due to stagnant economy.

Pouch Tapes Market

Key Players

Some of the key players in the field of pouch tapes market are 3M, Irplast S.p.A., Lynx Polythene Ltd., and Flexopack Ltd., among together.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on

Market Segments
Market Dynamics

Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology

Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)

Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Access Full Report: https://www.futuremarketinsights.com/reports/pouch-tapes-market

Pouch Tapes Market: Market Segmentation

Pouch tapes market has been segmented on the basis of material types, width, and end-use.

On the basis of material type, pouch tapes has been segmented as

Polypropylene
Polyethylene
LDPE

HDPE
Others

On the basis of width, pouch tapes market has been segmented as

Less than 5”
5” to 6”

Above 6”

On the basis of end-use, pouch tapes market has been segmented as

Shipping and logistics
Food and beverages
E-commerce
Warehouse shipping
Commercial
Others

Global Poultry Packaging Market to Reach USD 3.85 Billion by 2033 with Rigid Packaging Leading the Way

The global poultry packaging market is projected to reach a valuation of USD 3.85 billion by 2033, expanding at a CAGR of 4.0% from USD 2.6 billion in 2023, according to the latest analysis by Future Market Insights (FMI). This growth is driven by increasing demand for nutritious poultry products and the preference for rigid packaging solutions, which offer superior protection.

Market Overview: In 2021, the poultry packaging market generated USD 2.4 billion in revenue, and with the continued demand for high-nutrition poultry food, the market is forecasted to accelerate at a CAGR of 5.0% over the forecast period.

The food packaging industry is experiencing rapid growth and expansion, which is set to have a positive impact on the Poultry Packaging Market. Projections indicate that the Poultry Packaging Market is poised for remarkable growth, expected to increase by 1.7 times its current market value during the forecast period. This robust expansion can be attributed to several key factors driving the demand for poultry packaging.

In order to keep the food safe, secure and to extend the shelf life of the products various preservative techniques are used in the packaging industry. In addition, another factor contributing to the growth of poultry packaging is the initiatives from the various governments to increase healthy food products.

Drivers:

Increased Poultry Consumption: The rising global consumption of poultry products, including chicken and turkey, is a significant driver for the Poultry Packaging Market. As more people incorporate poultry into their diets, the demand for effective packaging solutions grows.
Food Safety and Regulations: Stringent food safety regulations require proper packaging to maintain the quality and safety of poultry products. This drives the need for advanced packaging solutions that can ensure product integrity and safety.
Packaging Innovations: Ongoing innovations in packaging materials and technologies enhance the shelf life of poultry products, reduce food waste, and improve overall product quality. This drives the adoption of new packaging solutions.
Convenience and Portability: Consumers’ busy lifestyles have increased the demand for convenient, ready-to-eat, and on-the-go poultry products. Packaging that offers convenience, easy access, and portion control is in high demand.

Competitive landscape:

The Poultry Packaging Market is highly competitive, with numerous significant companies competing for market share. Sealed Air Corporation, Smurfit Kappa Group, and DS Smith lead the industry, providing various chicken packaging options such as Hoover bags, trays, and shrink films. Amcor Limited, Coveris Holdings S.A., and Silgan Holdings Inc. are all strong rivals, offering novel packaging materials and solutions adapted to the poultry industry’s specific requirements. The fierce competition encourages constant developments in packaging technology and sustainability, which benefits the poultry sector by providing efficient and ecologically friendly packaging options.

Recent Developments:

Sealed Air provides innovative poultry packaging solutions, such as Hoover bags and shrink films, to preserve food freshness and shelf life. Their research focuses on environmentally friendly materials and novel packaging solutions to reduce food waste and promote sustainability.
Smurfit Kappa offers a variety of chicken packaging alternatives, including corrugated boxes and trays, to provide the best product protection and handling. Their research focuses on lightweight and recyclable packaging solutions that decrease environmental impact while improving supply chain efficiency.
DS Smith specializes in poultry packaging solutions, including innovative molded fiber trays as well as environmentally friendly packaging materials. Their innovations include customized packaging solutions for various chicken products that strive to fulfill the industry’s demanding cleanliness and safety standards.

Access Full Report: https://www.futuremarketinsights.com/reports/poultry-packaging-market

Poultry Packaging Market by Category

By Material:

Plastic
Paper
Molded Pulp

By Packaging Type:

Rigid Packaging
- Trays
- Bowls
- Cans
- Boxes
Flexible Packaging
- Pouches
- Wraps
- Bags
- Films

By Distribution Channel:

E-commerce
Retail Stores
Convenience Stores

By Region:

North America
Latin America
Europe
South Asia
East Asia
Middle East & Africa
Oceania

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Aseptic Paper for Packaging Market to Reach USD 15.82 Billion by 2033, Driven by Technological Innovation and Expanding Applications

The global aseptic paper for packaging market is projected to witness substantial growth, reaching a valuation of USD 15,818.84 million by 2033 from USD 9,804.37 million in 2023, with a CAGR of 4.9% during the forecast period (2023-2033), according to a recent analysis. This growth is attributed to expanding applications and continuous technological innovation in the packaging industry.

Market Dynamics: The global packaging industry is experiencing rapid expansion due to innovations and advancements that provide a competitive edge for manufacturers. Aseptic packaging has emerged as a key solution, enabling extended shelf life for various products without refrigeration.

Delicate food items such as milk, soy beverages, juices, and nectars are stored in aseptic packaging, which helps to preserve their freshness and nutritional value. The demand for aseptic paper is rising as it offers superior preservation capabilities, making it a preferred solution for packaging these sensitive products.

Aseptic paper packaging is a type of packaging material designed to maintain the freshness and extend the shelf life of liquid products without the need for refrigeration or preservatives. The aseptic packaging process involves sterilizing both the packaging material and the product separately and then filling and sealing the packaging in a sterile environment. This ensures that the packaged product remains uncontaminated by microorganisms, allowing it to be stored at ambient temperatures for an extended period.

The expanding market for aseptic paper for packaging is notably driven by the escalating consumption of pre-cooked foods, dairy products, juices, and meat, which necessitate aseptic packaging solutions. Furthermore, aseptic paper for packaging is highly sought after due to its lightweight nature, energy efficiency, and inherent durability, making it a preferred choice for manufacturers and consumers alike. This not only underscores the versatility of aseptic paper but also positions it as an eco-conscious solution aligned with modern packaging preferences.

Market Trends:

Rising Demand for Convenience: Consumers’ preference for convenient, on-the-go products has contributed to the increased adoption of aseptic paper packaging for various liquid products.
Focus on Sustainability: The packaging industry is placing a growing emphasis on sustainable practices, and aseptic paper packaging aligns with this trend as it is often made from renewable resources and is recyclable.
Innovation in Packaging Design: Ongoing research and development efforts are focused on innovating aseptic paper packaging designs and materials to enhance functionality, sustainability, and visual appeal.
Global Expansion: Aseptic paper packaging is witnessing increased adoption globally, with manufacturers expanding their production capacities to meet the rising demand for this packaging solution.

Start Up Ecosystem

Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a large customer base. For instance,

Greatview Aseptic Packaging Company is an aseptic processing firm headquartered in Beijing, China, Established in 2003. The bio-attributed polymers, which are incorporated into Greatview’s production process via an RSB® certified mass balance approach*, might be linked to tall oil, a natural by-product of paper manufacturing sourced from responsibly managed forests, in December 2021.

Market Drivers:

The aseptic food and beverage packaging method involves pasteurization before filling with Ultra-Heat-Treated (UHT) products, effectively extending the shelf life of the contents. The UHT process not only enhances product longevity but also ensures maximum microorganism elimination, particularly beneficial for dairy products and alternatives. This cost-effective and versatile technology has become integral in preserving the quality and shelf life of packaged products.

Packaging liquid food products using plastics derived from nonrenewable sources poses a significant environmental threat, with prolonged consequences for marine life. In response to stringent governmental regulations aimed at curbing the use of single-use plastics, packaging solution providers are steering away from traditional methods and embracing eco-friendly alternatives.

Ultra-pasteurized milk, undergoing a unique pasteurization and packaging process, is stored in sterilized containers, granting it storability for several months. The use of aseptic cartons for UHT milk eliminates the need for refrigeration until the package is opened, allowing for an extended preservation period lasting several months.

Access Full Report: https://www.futuremarketinsights.com/reports/aseptic-paper-packaging-market

Key Players

Tetra Pak International S.A.

Nampak Ltd.

SIG Combibloc Obeikan (South Africa) (Pty) Ltd.

Mondi Ltd

Polyoak Packaging Group (Pty) Ltd.

Amcor Limited

Elopak SA

IPI s.r.l.

Uflex Ltd

Ducart Group

Key Segmentation

Aseptic Paper for Packaging Market by Paper Type:

Aseptic Bleached Paperboard
Aseptic Coated Unbleached Kraft Paperboard

Aseptic Paper for Packaging Market by Thickness:

Aseptic Paper up to 100 microns
Aseptic Paper from 100 to 200 microns
Aseptic Paper from 200 to 300 microns
Aseptic Paper above 300 microns

Aseptic Paper for Packaging Market by End Use:

Food & Beverage Packaging
Dairy Packaging
Pharmaceuticals Packaging

Aseptic Paper for Packaging Market by Region:

North America
Latin America
Europe
East Asia
South Asia & Oceania
The Middle East & Africa

About Future Market Insights (FMI)

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Global Parkinson’s Disease Market Set for USD 6.7 Billion Valuation, Powered by a 5.1% CAGR, from 2024 to 2034

The Global Parkinson’s Disease Industry is poised to achieve an estimated worth of USD 5.41 Billion, reflecting a notable increase from the USD 4.82 Billion recorded in the fiscal year 2022. The projected growth trajectory for this decade, spanning from 2024 to 2034, anticipates a consistent annual growth rate of 5.1%, leading to a projected market value of USD 6.7 Billion by the conclusion of 2034.

Parkinson’s disease, a complex brain disorder characterized by the degeneration of nerve cells in a specific brain region, manifests in a myriad of ways, encompassing symptoms such as rigidity, emotional fluctuations, cognitive impairments, coordination and balance challenges, fluctuations in blood pressure, and cognitive functions. While Parkinson’s disease remains incurable, it is crucial to recognize the availability of various treatment modalities, including surgical interventions, pharmaceutical therapies, and other advanced medical approaches.

When a patient’s medications are not functioning effectively, it can lead to an increase in Parkinson’s disease (PD) symptoms including tremor and walking problems, which is known as an “off episode.” In the US, NOURIANZ (istradefylline), an antagonist of the adenosine A2A receptor, is used for Parkinson’s disease. The medication offers patients with Parkinson’s disease a brand-new non-dopaminergic once-daily oral treatment alternative. Such developments are expected to spur global growth in the Parkinson’s disease market from 2023-2033.

Key Takeaways from the Market Study

The global Parkinson’s disease market is currently worth more than US$ 4.82 Billion.
In 2023, the Carbidopa-levodopa segment by drug class type is expected to take the dominant market share of 32%.
In 2023, considering the age type, the adult segment is predicted to gain a 21% market share.
The North American market for Parkinson’s disease is predicted to grow with a steady CAGR of 12.5% from 2023-2033.
The APAC for Parkinson’s disease is expected to grow with a steady CAGR of 12% during 2023-2033.

“The market is anticipated to expand as more drugs are approved for the treatment of Parkinson’s disease and as there is a robust pipeline of novel medications being developed for the condition.” comments a Future Market Insights analyst.

Competitive Landscape

Some of the top players in the global Parkison’s disease market are:

Sunovion Pharmaceuticals
Adamas Pharmaceuticals
Neurocrine Biosciences
Supernus Pharmaceuticals
Alectos Therapeutics
Kyowa Kirin
AbbVie
Integrative Research Laboratories AB
Annovis Bio Inc.
Cerevel Therapeutics
Biogen Inc.
Amneal Pharmaceuticals

Some of the recent developments in this domain are:

Biogen Inc. and Alectos Therapeutics signed an agreement in June 2022 to develop and market GBA2 inhibitors (AL01811), a possible therapy for Parkinson’s disease patients. This agreement grants Biogen worldwide rights to research, manufacture, and commercialize AL01811. They think they will be well-suited to assist in bringing AL01811 to patients who need it by combining Alectos’ experience in small-molecule therapies with Biogen’s worldwide development expertise in Parkinson’s disease. They are indeed energized by the prospect of using Biogen’s commercial skills to raise the standard of treatment in Parkinson’s disease as well as movement disorders in general.

More Valuable Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Parkinson’s disease Industry, presenting historical demand data (2018-2022) and forecast statistics from 2023 to 2033.

The study divulges essential insights on the market based on the Parkinson’s disease industry by type (juvenile parkinson disease, young-onset parkinson’s disease, idiopathic parkinson disease), by age (adult and pediatric), by diagnosis (CT Scan, MRI Scan, DaTSCAN-SPECT scan, PET Scan), by drug class (carbidopa-levodopa, carbidopa-levodopa infusion, dopamine agonists, monoamine oxidase b inhibitors, catechol o-methyltransferase inhibitors, anticholinergics, amantadine) and regions.

A Full Report Overview

Key Segments Profiled in the Amyotrophic Lateral Sclerosis Industry Survey

Treatment:

Medication
Stem Cell Therapy
Others

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Others

Region:

North America
Latin America
Europe
Asia Pacific
MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Oncolytic Adenovirus Market Targets USD 250 Billion Valuation by 2033 at a 7.5% of CAGR

During the forecast period 2023 to 2033, the oncolytic adenovirus market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for oncolytic adenovirus is expected to rise up to a market valuation of USD 250 Billion. Growth of the market can be attributed to increasing investments by key players for research and development of medication for oncolytic adenovirus.

The COVID-19 pandemic affected the development of the oncolytic adenovirus owing to the disruption in the research and development of medication. Lack of funds and access to resources to develop and innovate therapies is affecting the growth of the market. On the other hand, post-pandemic, the increasing use of technology in the formation of therapies is positively influencing the growth of the oncolytic adenovirus market.

The prevalence of people being affected by cancer in North America and Asia Pacific is a key driver for the growth of the oncolytic adenovirus market. Increasing healthcare expenditure and integration of technology to understand the nature and effect of oncolytic adenovirus is propelling the growth of the overall market. In the upcoming forecast period, funding by government and non-government organizations is expected to drive the overall growth of the market.

Key Takeaways :

The oncolytic adenovirus market is expected to possess 7.5% CAGR in the forecast period 2023-2033
By application, lung cancer is expected to possess 35% market share for oncolytic adenovirus in 2023.
North America is expected to possess 43% market share for Oncolytic adenovirus market in 2023.
Asia Pacific oncolytic adenovirus market size is expected to possess 39% market share in 2023.

“Growing prevalence of cancer amongst all age groups along with technological integration to create therapeutic medication is creating lucrative opportunities for oncolytic adenovirus market.” states a FMI analyst

Competitive Landscape

Key players in the oncolytic adenovirus market are Amgen, Sorrento Therapeutics, Transgene SA, Oncolys BioPharma, Targovax, Lokon Pharma, Vyriad, TILT Biotherapeutics, CG Oncology Inc, VCNBiosciences, DNAtrix, Replimune Group Inc

Lokon Pharma AB is a Swedish biotech company developing the LOAd platform of oncolytic adenoviruses genetically engineered to express immunostimulatory genes in malignant tumors and tumor stroma.

TILT Biotherapeutic’s head of R&D Riikka Havunen was awarded oral presentation “Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable treatment of solid tumors with T cell therapies” at the 16th Cancer Immunotherapy Annual Meeting in Mainz, Germany in May 2018.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Oncolytic adenovirus market, presenting historical analysis from 2017 to 2022 and forecast statistics for the period of 2023-2033.

The study reveals essential insights on the basis of Type (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Others), Application (Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Others), regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

A Full Report Overview

Key Segments :

Type:

HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Others

Application:

Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Clostridium Difficile Infections Treatment Market Set to Reach USD 1,448.75 Million by 2033, Growing at a CAGR of 6%

The global Clostridium Difficile Infections (CDI) treatment market is poised for significant growth over the next decade. Valued at an impressive USD 809 million in 2023, the market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 6%, reaching approximately USD 1,448.75 million by 2033.

Clostridium Difficile, also known as C. difficile, is a bacterium that causes infections leading to severe diarrhea and inflammation of the colon, predominantly affecting older adults in healthcare settings. The growing incidence of C. difficile infections and increasing awareness regarding effective treatments are driving the demand for CDI therapies.

Innovations in medical research and treatment approaches, along with rising healthcare expenditure, are expected to propel market growth further in the coming years.

Rising Utilization of Antibiotics accelerates Market Growth

Long-term antibiotic consumption is the most common cause of Clostridium difficile infection. Antibacterial drugs use changes the colorectal bacteria, enabling Clostridium difficile bacteria to thrive. Cephalosporins, clindamycin, and quinolone antibiotics seem to be more susceptible to causing Clostridium difficile infection (CDI).

The elevated utilization of these antibiotics is expanding the likelihood of Clostridium difficile infection, which is predicted to boost the requirement for its treatments. As a result, increased antibiotic usage is an important driver of expansion in the worldwide clostridium difficile infection treatment market.

Market Competition

Key players in the Difficile Infections (Clostridium Difficile Associated Disease) Treatment market are Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc., Trinity Biotech, Summit Therapeutics, Baxter International Inc., Sanofi S.A., Novartis AG, and AstraZeneca Plc.

Thermo Fisher ScientificTM XpectTM C. difficile Toxin A/B Test, which was launched in September 2021 by Thermo Fisher Scientific Inc, detects Clostridium difficile toxins A and B in human fecal specimens. It incorporates superior clinical efficiency with a simple three-step method.
Tech Lab’s TOX A/B QUIK CHEK® test is a rapid enzymatic immunoassay that was launched in February 2021. The test employs antibodies against C. difficile toxins A and B. The device comprises a Response Window with two stripes. One stripe denotes a toxin A and B test line. The other striped line is the monitoring line.

Key Companies Profiled:

Merck & Co. Inc.;
Baxter International Inc.;
Sanofi S.A;
Pfizer Inc.;
Novartis AG;
Astellas Pharma;
Eli Lily & Company;
AstraZeneca;
Actelion Pharmaceuticals Ltd.;
Mylan N.V

A Full Report Overview

Key Segments Profiled in the Difficile Infections (Clostridium Difficile Associated Disease) Treatment Market Industry Survey

By Treatment:

Antimicrobial Therapy
Faecal Microbiota Transplantation

By Drug Type:

Metronidazole
Vancomyci
Fidaxomicin

By End User:

Hospital
Pharmacies
ASCs

By Region:

North America
Western Europe
Eastern Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market is projected to grow at a CAGR of 9.5% totaling around USD 19.52 Billion by 2033

The global Nucleic Acid And Gene Therapies In Neuromuscular Disorders market size is expected to be valued at USD 7.88 Billion in 2023. With the increasing high incidence of cancer and other target diseases, the overall demand for Nucleic Acid And Gene Therapies In Neuromuscular Disorders is projected to grow at a CAGR of 9.5% between 2023 and 2033, totaling around USD 19.52 Billion by 2033.

The diagnosis of neuromuscular disorders is performed through physical examination as well as certain diagnostic tests. A physician runs a complete medical history assessment to determine if any family member had previously had symptoms of neuromuscular disorders, to assess the condition of a patient.

The global nucleic acid and gene therapies in neuromuscular disorders market is driven by major factors such as rise in government initiatives to ensure early diagnosis, an increase in awareness about genetic disorders, an upsurge in research and development activities, and improvement in healthcare infrastructure.

Factors including the expanding investments by key market players, a strong product portfolio, as well as a high prevalence of target diseases and interest in innovative and new therapy are expected to escalate the market growth in the forthcoming years. In addition, the increased investment in research and development by government and private organizations are anticipated to further create lucrative avenues for the market growth over the analysis period.

In recent years, the rapid technological advancements in cellular and molecular biology in genomics research are other factors that have been contributing greatly to the market growth. The academicians, researchers, and in-house researchers of major market companies with significant funding have all played critical roles.

The frequency of cardiovascular diseases is increasing in many industrialized countries, and there is a growing need to cure these diseases in less time, resulting in players investing extensively in research and development of highly effective and innovative therapeutics such as gene therapy. The prevalence of rare diseases such as cardiovascular and cancer diseases will have positive impact on the demand for gene therapy applications. This in turn is likely to expand the market growth in the near future.

Currently, only a few market players are dominating the market growth, and are significantly contributing to the market’s expansion. The core members who are working on item dispatching and other important coordinated activities to strengthen their market reach globally. In order to increase their cancer gene therapy research and product portfolio, local and small market players are increasingly partnering and developing alliances with large market players.

Key Takeaways from the Market Study

Global Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market was valued at US$ 7.19 Bn by 2022-end
From 2018 to 2022, the market demand expanded at a CAGR of 5%
By Therapy, the Spinal Muscular Atrophy segment of the market constitutes the bulk of the market with a market share of 46%
By Application, the Hospitals segment dominates the market with a share of 45%
From 2023 to 2033, Nucleic Acid And Gene Therapies in Neuromuscular Disorders sales are expected to flourish at a CAGR of 5%.
By 2033, the market value of Nucleic Acid And Gene Therapies in Neuromuscular Disorders is expected to reach US$ 52 Bn.

Increasing research and development, as well as the growing prevalence of neuromuscular disease are the major factors that are expected to accelerate the growth of the Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market during the forecast period, remarks an FMI analyst.

Competitive Landscape

Prominent players in the Nucleic Acid And Gene Therapies In Neuromuscular Disorders market are Pfizer, Inc., F. Hoffmann-La Roche Ltd., UCB Pharma, Biogen, Astellas Pharma, Inc., Novartis AG, Abbott Laboratories, Inc., and Sanofi, among others.

Recent Developments:

In May 2021, Biogen and Capsigen collaborated to discover as well as develop novel AAV Capsids with enhanced properties to facilitate the development of new gene therapies for targeted CNS and Neuromuscular Disorders. Capsigen’s screening technology is designed to produce dose optimized, fit for purpose vectors that may have applicability across Biogen’s gene therapy pipeline. Capsigen received a $15 million upfront payment and is eligible to receive potential research, development and commercial milestone payments.
In June 2019, Vertex Pharmaceuticals Incorporated announced the enhancement of its gene editing capabilities to develop novel therapies for Duchenne Muscular Dystrophy (DMD) and Myotonic Dystrophy Type 1 (DM1) by expanding its collaboration with CRISPR Therapeutics and acquiring Exonics Therapeutics. Vertex and CRISPR Therapeutics had expanded their collaboration and entered into an exclusive licensing agreement to discover and develop gene editing therapies for the treatment of DMD and DM1.

Know More About What the Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market Repost Covers

Future Market Insights offers an unbiased analysis of the global Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market, providing historical data for 2018-2022 and forecast statistics from 2023-2033. To understand opportunities in the Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market, the market is segmented on the basis of disorder, therapy, and application, across five major regions.

A Full Report Overview

Key Segments Covered in the Nucleic Acid And Gene Therapies In Neuromuscular Disorders Industry Analysis

Nucleic Acid And Gene Therapies In Neuromuscular Disorders Market by Disorder:

Motor Neuron Diseases
Neuropathies
Neuromuscular Junction Disorders
Myopathies including Muscular Dystrophies

Nucleic Acid And Gene Therapies In Neuromuscular Disorders Market by Therapy:

AAV Gene Therapy
Postnatal Gene Therapy
Spinal Muscular Atrophy

Nucleic Acid And Gene Therapies In Neuromuscular Disorders Market by Application

Hospitals
Specialty Clinics
Ambulatory Surgery Centers

Nucleic Acid And Gene Therapies In Neuromuscular Disorders Market by Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Necrobiosis Lipoidica Diabeticorum Market is projected to reach USD 8.06 Billion by 2033, at a CAGR of 6%

The global Necrobiosis Lipoidica Diabeticorum (NLD) market is expected to be worth USD 4.5 billion in 2023 and USD 8.06 billion by 2033, with a CAGR of 6% from 2023 to 2033. The market for Necrobiosis Lipoidica Diabeticorum (NLD) expanded at a CAGR of 4% between 2017 and 2022.

Diabetes’ rising prevalence can be attributed to the expansion of the Necrobiosis Lipoidica Diabeticorum (NLD) business. According to the International Diabetes Federation, diabetes would be responsible for 6.7 million deaths by 2021. Diabetes is becoming more common in places such as the Middle East and Asia Pacific, fueling the development of NLD. Growth is expected to be bolstered as a result of the presence of untapped growth potential in quickly rising MEA and Asian economies, as well as improved diabetes awareness in these regions.

Key Takeaways from the Market Study

The Necrobiosis Lipoidica Diabeticorum (NLD) market increased at a 4% CAGR from 2017 to 2022.
The global market for Necrobiosis Lipoidica Diabeticorum (NLD) is predicted to increase at a 6% CAGR from 2023 to 2033.
The market for Necrobiosis Lipoidica Diabeticorum (NLD) is estimated to reach $8.06 billion by 2033.
Hospitals have the biggest market share, according to the FMI research.
North America is estimated to have 34% of the market for Necrobiosis Lipoidica Diabeticorum (NLD).
With a CAGR of 5% during the forecast period, the Asia Pacific market is expected to grow significantly throughout the projected period.

“Various factors such as awareness in wellness and health, the diagnostics, and pathology segment are improving in the developing countries nowadays which grows the therapeutics market. The research and development activities in the field like emerging novel therapeutics, increasing the efficacy of medicine as well as treatment.” says an FMI analyst

Market Competition

Key players in the Necrobiosis Lipoidica Diabeticorum (NLD) market are ALexicare Pharma, Andréas Astier, Mayo Clinic, AbbVie Inc, Merck & Co., Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services Inc., Pfizer, Novartis AG, and GlaxoSmithKline Plc.

Basilea Pharmaceutica Ltd revealed today good topline findings for the Phase III ERADICATE study, investigating ceftobiprole in the treatment of adult patients with Staphylococcus aureus (SAB) bacterial bloodstream infections.
Paladin Labs Inc., a subsidiary of Endo International PLC, launched Xydalba (dalbavancin for injection) in January 2022, a 30-minute intravenous (IV) therapy for acute bacterial skin and skin structure infections (ABSSSI) that can be given in a single or two-dose regimen.

More Insights Available

Geographically, the necrobiosis lipoidica treatment market is concentrated in developed regions, such as North America and Europe, where there is a higher prevalence of the disease due to the higher incidence of diabetes in these regions. However, the market is expected to grow in emerging economies such as India and China, as the prevalence of diabetes increases in these regions.

Overall, the necrobiosis lipoidica market is small but growing, and is expected to continue to grow in the coming years as more treatment options become available and the prevalence of the disease increases.

A Full Report Overview

Key Segments Profiled in the Necrobiosis Lipoidica Diabeticorum (NLD) Industry Survey:

Procedure:

Treatment
- Corticosteroid Creams
- Injected Corticosteroids
- Drugs that Suppress the Immune System
- Anti-inflammatory Drugs
- Medicines that Improve Blood Flow
- Hyperbaric Oxygen Therapy
- Phototherapy
- Laser Therapy

Test Type
- Punch Biopsy
- Glucose Tolerance Test

Application:

Hospitals
Ambulatory Clinics

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Pelvic Cancer Induced Hemorrhegic Cystitis Market to Surpass an Impressive Valuation of USD 11 Billion by 2033, with a CAGR of 18.01%

The global pelvic cancer induced hemorrhagic cystitis market size is estimated to achieve an amazing valuation of USD 2.1 billion in 2023 and reach USD 11 billion by 2033, at a CAGR of 18.01%.

Rising awareness among the population regarding early treatment and diagnosis for related disorders, coupled with the steady shift towards unhealthy diets and sedentary lifestyles, is driving the market demand. Advancements in drug development have enabled physicians to administer drugs directly to the infected tissues without harming surrounding healthy tissues, which has contributed to increasing patient compliance, which in turn is expected to boost industry growth.

The high research and development cost associated with the manufacturing of hemorrahagic cystitis treatment drugs, coupled with increased penetration of generic drugs, is likely to restrain market growth. However, technological advancements in drug development to manufacturing cost-effective and side-effect-free drugs are anticipated to create opportunities for industry movements. Moreover, the use of High approval rate of Ifosfamide and cyclophosphamide for use in a variety of malignancies, both in children and adults are driving the market for Haemorrhagic Cystitis. North America dominates the market for Pelvic Cancer induced Hemorrhagic Cystitis with market valuation of US$ 3.6 Billion, followed by APAC.

Key Takeaways

North American Pelvic cancer induced hemorrhegic cystitis market is expected to reach US$ 3.6 Billion with a CAGR of 14.87% during the forecast period.
With a CAGR of 15.1%, APAC is projected to be fastest growing market for this haemorrhagic cystitis.
By treatment type, chemotherapy is expected to dominate the market with a 2/3^rd segment share.
Radiation therapy is anticipated to be a secondary treatment for hemorrhegic cystitis after Chemotherapy.
High cost of treatments and side-effects in post-treatment period will restrict market growth.
Adoption of combination therapies and novel therapies are expected to proliferate product demand.
Technological advancements in drug development for treatment of pelvic induced hemorrhagic cystitis is anticipated to strengthen market footprint.

“High investments in R&D, advancements in manufacturing drugs, adoption of cost-effective& side-effect-free drugs will open up new avenues for market expansion”- says an FMI Analyst

Competitive Landscape

Key players in the Pelvic cancer induced hemorrhagic Cystitis Market are: Johnson & Johnson Services, Inc, Astellas Pharma Inc, Eli Lilly and Company, Sanofi, Ipsen Pharma, Bayer AG, AstraZeneca, Valeant Pharmaceuticals International, Inc., Merck & Co., Inc., Pfizer Inc.

In April 2022, Pfizer made an equity investment worth USD 25 million in Zentalis Pharmaceuticals, Inc. This investment is expected to help Pfizer to leverage its development capabilities globally
In May 2022, Pfizer entered a research collaboration agreement of two years with NetVation DL Medicine. This collaboration is anticipated to aid and advance Pfizer in its research activities
In June 2022, Roche introduced a human papillomavirus (HPV) self-sampling solution that enables patients to perform HPV screening in the presence of a healthcare worker. This is expected to expand the company’s cancer screening solution line-up
In June 2022, Valencia Technologies Corporation announced the implantable neuromodulation technology product eCoin®, which is reshaping the delivery of long-term therapy for bladder control, is a tibial implant for Urge Urinary Incontinence (UUI). eCoin® received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) in March 2022, making it the first and only FDA-approved implantable tibial neurostimulator indicated for the treatment of urge urinary incontinence (UUI). This new product has helped the company to increase its portfolio.

A Full Report Overview

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the Bullous Keratopathy market, presenting historical analysis from 2017 to 2022 and forecast statistics for the period of 2023 to 2033.

Key Segments Profiled in the Pelvic Cancer Induced Hemorrhagic Cystitis Market Industry Survey

By Treatment:

Bone Marrow Transplant
Chemotherapy
- Cyclophosphamide
- Ifosfamide
Radiation Therapy
Other Treatments

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: